Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
NYSE:EHC
Total Valuation
Encompass Health has a market cap or net worth of $11.76B. The enterprise value is $13.65B.
Market Cap$11.76B
Enterprise Value$13.65B
Share Statistics
Encompass Health has 100,796,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,796,930
Owned by Insiders1.47%
Owned by Institutions0.80%
Financial Efficiency
Encompass Health’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 11.80%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)11.80%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee188.06K
Profits Per Employee20.98K
Employee Count28,572
Asset Turnover0.82
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Encompass Health is 20.25. Encompass Health’s PEG ratio is 0.70.
PE Ratio20.25
PS Ratio0.00
PB Ratio4.46
Price to Fair Value4.46
Price to FCF25.61
Price to Operating Cash Flow9.20
PEG Ratio0.70
Income Statement
In the last 12 months, Encompass Health had revenue of 5.37B and earned 455.70M in profits. Earnings per share was 4.56.
Revenue5.37B
Gross Profit2.47B
Operating Income864.50M
Pretax Income749.60M
Net Income455.70M
EBITDA1.19B
Earnings Per Share (EPS)4.56
Cash Flow
In the last 12 months, operating cash flow was 763.30M and capital expenditures -666.20M, giving a free cash flow of 97.10M billion.
Operating Cash Flow763.30M
Free Cash Flow97.10M
Free Cash Flow per Share0.96
Dividends & Yields
Encompass Health pays an annual dividend of $0.66, resulting in a dividend yield of 0.56%
Dividend Per Share$0.66
Dividend Yield0.56%
Payout Ratio14.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change38.99%
50-Day Moving Average101.47
200-Day Moving Average96.52
Relative Strength Index (RSI)71.07
Average Volume (3m)1.02M
Important Dates
Encompass Health upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateJul 01, 2025
Financial Position
Encompass Health as a current ratio of 1.05, with Debt / Equity ratio of 12.83%
Current Ratio1.05
Quick Ratio1.05
Debt to Market Cap0.27
Net Debt to EBITDA2.22
Interest Coverage Ratio6.29
Taxes
In the past 12 months, Encompass Health has paid 150.20M in taxes.
Income Tax150.20M
Effective Tax Rate0.20
Enterprise Valuation
Encompass Health EV to EBITDA ratio is 9.99, with an EV/FCF ratio of 32.90.
EV to Sales2.21
EV to EBITDA9.99
EV to Free Cash Flow32.90
EV to Operating Cash Flow11.82
Balance Sheet
Encompass Health has $95.80M in cash and marketable securities with $369.60M in debt, giving a net cash position of $273.80M billion.
Cash & Marketable Securities$95.80M
Total Debt$369.60M
Net Cash$273.80M
Net Cash Per Share$2.72
Tangible Book Value Per Share$12.69
Margins
Gross margin is 36.45%, with operating margin of 16.09%, and net profit margin of 8.48%.
Gross Margin36.45%
Operating Margin16.09%
Pretax Margin13.95%
Net Profit Margin8.48%
EBITDA Margin22.08%
EBIT Margin16.51%
Analyst Forecast
The average price target for Encompass Health is $127.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$127.40
Price Target Upside9.22% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast11.21%
EPS Growth Forecast30.49%